Benzinga's Top Downgrades
- Goldman Sachs downgraded Adeptus Health Inc (NYSE: ADPT) from Buy to Neutral. Adeptus Health shares rose 2.21 percent to close at $8.79 on Thursday.
- Barclays downgraded Fitbit Inc (NYSE: FIT) from Overweight to Equal-Weight. Fitbit shares rose 1.06 percent to $8.60 in pre-market trading.
- Analysts at JP Morgan downgraded Aspen Aerogels Inc (NYSE: ASPN) from Overweight to Neutral. Aspen Aerogels shares fell 2.48 percent to close at $5.89 on Thursday.
- BMO Capital downgraded Brown & Brown, Inc. (NYSE: BRO) from Market Perform to Underperform. Brown & Brown shares rose 0.91 percent to close at $36.54 on Thursday.
- Analysts at William Blair downgraded El Pollo LoCo Holdings Inc (NASDAQ: LOCO) from Outperform to Market Perform. El Pollo Loco shares dropped 9.84 percent to $11.00 in pre-market trading.
- HSBC downgraded Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) from Buy to Hold. Teva shares rose 0.92 percent to $39.56 in pre-market trading.
- BMO Capital downgraded MDC Partners Inc (NASDAQ: MDCA) from Outperform to Market Perform. MDC Partners shares fell 48.21 percent to $4.35 in pre-market trading.
- Bank of America downgraded Whole Foods Market, Inc. (NASDAQ: WFM) from Neutral to Underperform. Whole Foods shares declined 1.44 percent to $28.05 in pre-market trading.
- Analysts at Raymond James downgraded Papa Murphy's Holdings Inc (NASDAQ: FRSH) from Outperform to Market Perform. Papa Murphy's shares declined 23.43 percent to close at $4.02 on Thursday.
- Analysts at DA Davidson downgraded Fluor Corporation (NEW) (NYSE: FLR) from Buy to Neutral. Fluor shares fell 15.41 percent to $43.81 in pre-market trading.
Latest Ratings for ADPT
Date | Firm | Action | From | To |
---|---|---|---|---|
Nov 2020 | Morgan Stanley | Maintains | Equal-Weight | |
Sep 2020 | Morgan Stanley | Initiates Coverage On | Equal-Weight | |
May 2020 | Guggenheim | Maintains | Buy |
View More Analyst Ratings for ADPT
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Top DowngradesDowngrades Analyst Ratings